Press Releases Orphazyme A/S

Equities

Delayed Nasdaq Copenhagen Other stock markets 04:17:45 29/04/2024 pm IST			5-day change	1st Jan Change
1,090 ^DKK	0.00%		+8.46%	-18.05%

27/03	Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04/03	FDA Extends Review of Zevra's Arimoclomol by Three Months	DJ

STALICLA Appoints Dr. Thomas Blaettler, MD	12/04	AQ
BioStock: Comments from Orphazyme on the investment in CombiGene	04/03	AQ
The Danish company Orphazyme has acquired 10% of the shares in CombiGene	21/02	AQ
Myositis Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)	10/23/10	AQ
Niemann-Pick-Disease Pipeline, FDA Approvals, Clinical Trials, and Emerging Drugs 2023 (Updated)	28/23/28	AQ
Change in management	30/23/30	GL
Major shareholder announcement	19/23/19	GL
Major shareholder announcement	17/23/17	GL
Resolutions passed at the Annual General Meeting	17/23/17	GL
Changes to the Board of Directors	17/23/17	AQ
Changes to the Board of Directors	17/23/17	GL
Major shareholder announcement	12/23/12	GL
Major shareholder announcement	09/23/09	GL
Major shareholder announcement	09/23/09	GL
Major shareholder announcement	09/23/09	AQ
Notice to convene Annual General Meeting	26/23/26	GL
Notice to convene Annual General Meeting	26/23/26	AQ
Adjusted financial outlook for 2022	26/22/26	GL
Adjusted financial outlook for 2022	26/22/26	GL
Updated financial calendar for 2022	19/22/19	GL

No results for this search